Cited by 1,485Cardiomyopathy and Myosin StudiesGenomics and Rare DiseasesCardiac electrophysiology and arrhythmias

Truncations of titin causing dilated cardiomyopathy

Open access
Herman, Daniel S., Lam, Lien, Taylor, Matthew R.G., Wang, Libin, Teekakirikul, Polakit, Christodoulou, Danos, Conner, Lauren, DePalma, Steven R. +21 more·2012·New England Journal of Medicine

Abstract

BACKGROUND: Dilated cardiomyopathy and hypertrophic cardiomyopathy arise from mutations in many genes. TTN, the gene encoding the sarcomere protein titin, has been insufficiently analyzed for cardiomyopathy mutations because of its enormous size. METHODS: We analyzed TTN in 312 subjects with dilated cardiomyopathy, 231 subjects with hypertrophic cardiomyopathy, and 249 controls by using next-generation or dideoxy sequencing. We evaluated deleterious variants for cosegregation in families and assessed clinical characteristics. RESULTS: We identified 72 unique mutations (25 nonsense, 23 frameshift, 23 splicing, and 1 large tandem insertion) that altered full-length titin. Among subjects studied by means of next-generation sequencing, the frequency of TTN mutations was significantly higher among subjects with dilated cardiomyopathy (54 of 203 [27%]) than among subjects with hypertrophic cardiomyopathy (3 of 231 [1%], P=3×10(-16)) or controls (7 of 249 [3%], P=9×10(-14)). TTN mutations cosegregated with dilated cardiomyopathy in families (combined lod score, 11.1) with high (>95%) observed penetrance after the age of 40 years. Mutations associated with dilated cardiomyopathy were overrepresented in the titin A-band but were absent from the Z-disk and M-band regions of titin (P≤0.01 for all comparisons). Overall, the rates of cardiac outcomes were similar in subjects with and those without TTN mutations, but adverse events occurred earlier in male mutation carriers than in female carriers (P=4×10(-5)). CONCLUSIONS: TTN truncating mutations are a common cause of dilated cardiomyopathy, occurring in approximately 25% of familial cases of idiopathic dilated cardiomyopathy and in 18% of sporadic cases. Incorporation of sequencing approaches that detect TTN truncations into genetic testing for dilated cardiomyopathy should substantially increase test sensitivity, thereby allowing earlier diagnosis and therapeutic intervention for many patients with dilated cardiomyopathy. Defining the functional effects of TTN truncating mutations should improve our understanding of the pathophysiology of dilated cardiomyopathy. (Funded by the Howard Hughes Medical Institute and others.).

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1056/nejmoa1110186

Cites

43 of 43 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • SORBS1 and MAP4K4 had multiple noncanonical isoforms that were detectable across multiple tissues, whereas titin had the most isoforms identified.

    “A number of proteins including SORBS1 and MAP4K4 had multiple noncanonical isoforms that were detectable across multiple tissues, whereas the protein with the most isoforms identified was titin (Figure 3A), which is also the largest protein in the human genome with the most exons and whose splicing has been widely implicated in congenital heart diseases (Guo et al., 2012; Herman et al., 2012).”

    From Splice-Junction-Based Mapping of Alternative Isoforms in the Human Proteome (2019) · cites this paper as Herman et al., 2012

  • Mutations in TTN are associated with familial dilated cardiomyopathy in humans.

    “mutations in TTN are associated with familial dilated cardiomyopathy (Herman et al., 2012).”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Herman, D. S., Lam, L., Taylor, M. R. G., Wang, L., Teekakirikul, P., Christodoulou, D., Conner, L., DePalma, S. R., McDonough, B., Sparks, E., Teodorescu, D. L., Cirino, A. L., Banner, N. R., Pennell, D. J., Graw, S., Merlo, M., Di Lenarda, A., Sinagra, G., Bos, J. M., Ackerman, M. J., Mitchell, R. N., Murry, C. E., Lakdawala, N. K., Ho, C. Y., Barton, P. J. R., Cook, S. A., Mestroni, L., Seidman, J. G., & Seidman, C. E.
Affiliations
  • Harvard University (US)
  • Howard Hughes Medical Institute (US)
  • University of Colorado Denver (US)
  • Brigham and Women's Hospital (US)
  • Royal Brompton & Harefield NHS Foundation Trust (GB)
  • University of Trieste (IT)
  • Mayo Clinic (US)
  • University of Washington (US)
  • Imperial College London (GB)
Venue
New England Journal of Medicine
Published
2012-02-16
Volume
366
Issue
7
Pages
619-628
ISSN
  • 0028-4793 (ISSN-L)
  • 1533-4406
OpenAlex
W2167989424
Cited by
1,485
References
43
Citations by year
2026: 83 · 2025: 105 · 2024: 130 · 2023: 113 · 2022: 99 · 2021: 144 · 2020: 109 · 2019: 107 · 2018: 101 · 2017: 114 · 2016: 88 · 2015: 79 · 2014: 77 · 2013: 87 · 2012: 46
FWCI
59.47
Type
journal article
Language
en
Open access
Locations
  • New England Journal of Medicine (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
  • National University of Singapore (submittedVersion)
  • ArTS Archivio della ricerca di Trieste (University of Trieste https://www.units.it/) (submittedVersion)
Funders
  • Howard Hughes Medical Institute
  • British Heart Foundation (SP/10/10/28431)
  • National Institutes of Health (n01hv48194-8-0-1, UL1TR001082, 1u01hl098166-01)
  • National Heart, Lung, and Blood Institute (U01-HL098166, U01HL066582, R01HL084553, N01 HV048194, P01HL059139, P50HL052320, N01-HV-48194, R01HL080494)
  • National Institute of General Medical Sciences (T32GM007753)
  • National Center for Advancing Translational Sciences
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiomyopathy and Myosin Studies
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
Keywords
titin, TTN gene, dilated cardiomyopathy, hypertrophic cardiomyopathy, truncating mutations, sarcomere proteins, genetic testing, familial cardiomyopathy, mutation penetrance, nonsense mutation, frameshift mutation, splicing mutation
MeSH terms
Adult, Cardiomyopathy, Dilated, Female, Humans, Male, Middle Aged, Muscle Proteins, Mutation, Myocardium, Protein Kinases, Sequence Deletion, Sequence Analysis, DNA, Genotyping Techniques, Connectin

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review